Skip to main content

Overview

Quality use of medicines in people with diabetes 

The Commission has released four new resources to help health services address gaps and inconsistencies in care coordination and post-sepsis support for survivors, families, carers and those bereaved by sepsis.

Read the Spring 2025 issue of Commission eNews.

2025
Corporate

This communiqué provides an update on the ninth meeting of the National Sepsis Program Oversight Group (Oversight Group). It may be used by members to update their nominating organisations and other key agencies about the National Sepsis Program Extension (Program Extension). 

2025
Media release

Diabetes is one of Australia’s most pressing and complex health challenges, affecting more than 1.5 million people and contributing to long-term complications, hospitalisations and premature deaths. The National Medicines Symposium 2025, hosted by the Australian Commission on Safety and Quality in Health Care, will explore this issue under the theme ‘Quality use of medicines in people with diabetes’.

MEDIA RELEASE

The National Medicines Symposium 2025, hosted by the Australian Commission on Safety and Quality in Health Care, will explore this issue under the theme ‘Quality use of medicines in people with diabetes’.

Back to top